Zai Lab (ZLAB) Interest Coverage Ratio (2020 - 2026)
Zai Lab (ZLAB) reported Interest Coverage Ratio of 42.39 for Q1 2026, up 10.65% on a YoY basis from 38.3 in Q1 2025, and down 328.89% sequentially from 18.52 in Q4 2025.
Zai Lab (ZLAB) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Interest Coverage Ratio data on file, last reported at 42.39 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 10.65% year-over-year to 42.39; the trailing twelve-month figure through Mar 2026 stood at 440.12 (down 286.58% YoY), and the FY2025 full-year result was 0.53, up 25.19% from the prior year.
- Interest Coverage Ratio retreated to 42.39 in Q1 2026, from 18.52 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 983.93 in Q4 2024 to a low of 622.2 in Q1 2024.
- A 5-year average of 59.44 and a median of 43.5 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 180897.25% in 2023 and surged 258.72% in 2024, its largest moves.
- Tracing ZLAB's Interest Coverage Ratio over 5 years: stood at 0.34 in 2022, then slumped by 180897.25% to 619.9 in 2023, then surged by 258.72% to 983.93 in 2024, then sank by 98.12% to 18.52 in 2025, then tumbled by 328.89% to 42.39 in 2026.
- Business Quant data shows ZLAB's Interest Coverage Ratio at 42.39 in Q1 2026, 18.52 in Q4 2025, and 34.87 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | -42.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.39 |
| Dec 31, 2025 | 18.52 |
| Sep 30, 2025 | -34.87 |
| Jun 30, 2025 | -43.50 |
| Mar 31, 2025 | -47.44 |
| Dec 31, 2024 | 983.93 |
| Sep 30, 2024 | -91.08 |
| Jun 30, 2024 | -154.60 |
| Mar 31, 2024 | -622.20 |
| Dec 31, 2023 | -619.91 |
| Dec 31, 2022 | -0.34 |
| Dec 31, 2021 | -1.16 |
| Dec 31, 2020 | -3,969.00 |
| Sep 30, 2020 | -1,773.42 |
| Jun 30, 2020 | -1,526.65 |
| Mar 31, 2020 | -691.37 |